Table 1. Summary of hMSCs sources, cell surface markers and expansion media with serum supplements.
Source | Method of isolation | Media | Serum supplement | Cell surface markers | References | |
---|---|---|---|---|---|---|
Bone marrow | Ficoll density gradient method Novel marrow filter device |
DMEM DMEM-F12 ADMEM |
FBS | Positive | Negative | [10,36,38,47,48] |
CD73, CD90, CD105, STRO-1 | CD14, CD34, CD45, HLA-DR | |||||
Adipose tissue | Digestion method Membrane filtration method |
DMEM DMEM-LG |
FBS FCS |
CD73, CD090, CD29, CD44, CD71, CD105, CD13, CD166, STRO-1 | CD14, CD31, CD34, CD45 | [13,34,43,49,57] |
Amniotic fluid and membrane | Density gradient method Digestion method |
α-MEM DMEM/F12 |
FBS | CD29, CD44, CD90, CD105, CD, SH2, SH3, HLA-DR | CD10, CD14,CD34, HLA-DR | [15–17] |
Dental tissues | Digestion method | α-MEM MEM |
FCS FBS |
CD29, CD44, CD90, CD105 | CD14, CD34, CD45 | [18,19,46] |
Endometrium | Digestion method | DMEM-F12 | FCS | CD73, CD90, CD105, CD146 | CD34, CD45 | [20] |
Limb bud | Digestion method | DMEM-LG | FBS | CD13, CD29,CD90, CD105, CD106 | CD3, CD4, CD14, CD15, CD34, CD45, HLA-DR | [21] |
Peripheral blood | Ficoll density gradient | α-MEM | NBCS | CD44, CD90, CD105, HLA-ABC | CD45, CD133 | [23] |
Placenta and fetal membrane | Digestion method | DMEM-LG | FBS | CD29, CD73, CD90, CD105 | CD34, CD45 | [24] |
Salivary gland | Digestion method (Ringer solution) | DMEM | FCS | CD13, CD29, CD44, CD90, STRO-1 | CD34, CD45 | [25] |
Skin and foreskin | Digestion method | DMEM-HG DMEM DMEM-F12 |
FBS | CD44, CD73, CD90, CD105, CD166, SSEA-4, Vimentin | CD34, CD45, HLA-DR | [26,27] |
Sub amniotic umbilical cord lining membrane | Digestion method | DMEM-HG DMEM CMRL1660 |
FBS | CD29, CD44, CD73, CD90, CD105 | CD34, CD45 | [13,28,58] |
Synovial fluid | Ficoll density gradient method | α-MEM | FBS | CD44, CD90, CD105, CD147, STRO-1 | CD31, CD34, CD45, CD106 | [29] |
Wharton's jelly | Enzymatic digestion method | DMEM | FBS | CD73, CD90, CD105 | CD14, CD34, CD45, CD79, HLA-DR | [31,32] |